Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
Rubel DM, Spelman L, Murrell DF, See JA, Hewitt D, Foley P, Bosc C, Kerob D, Kerrouche N, Wulf HC, Shumack S. Rubel DM, et al. Br J Dermatol. 2014 Nov;171(5):1164-71. doi: 10.1111/bjd.13138. Epub 2014 Oct 20. Br J Dermatol. 2014. PMID: 24861492 Clinical Trial.
Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study.
Spelman L, Rubel D, Murrell DF, See JA, Hewitt D, Foley P, Salmon R, Kerob D, Pascual T, Shumack S, Fernandez-Penas P. Spelman L, et al. Among authors: rubel d. Australas J Dermatol. 2016 Feb;57(1):24-8. doi: 10.1111/ajd.12295. Epub 2015 Mar 31. Australas J Dermatol. 2016. PMID: 25827200 Free PMC article.
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
Blauvelt A, de Bruin-Weller M, Gooderham M, Cather JC, Weisman J, Pariser D, Simpson EL, Papp KA, Hong HC, Rubel D, Foley P, Prens E, Griffiths CEM, Etoh T, Pinto PH, Pujol RM, Szepietowski JC, Ettler K, Kemény L, Zhu X, Akinlade B, Hultsch T, Mastey V, Gadkari A, Eckert L, Amin N, Graham NMH, Pirozzi G, Stahl N, Yancopoulos GD, Shumel B. Blauvelt A, et al. Among authors: rubel d. Lancet. 2017 Jun 10;389(10086):2287-2303. doi: 10.1016/S0140-6736(17)31191-1. Epub 2017 May 4. Lancet. 2017. PMID: 28478972 Clinical Trial.
Psoriasis and cancer. An Australian/New Zealand narrative.
Rademaker M, Rubel DM, Agnew K, Andrews M, Armour KS, Baker C, Foley P, Gebauer K, Goh MS, Gupta M, Marshman G, Prince HM, Sullivan J. Rademaker M, et al. Australas J Dermatol. 2019 Feb;60(1):12-18. doi: 10.1111/ajd.12889. Epub 2018 Jul 10. Australas J Dermatol. 2019. PMID: 29992535 Free article. Review.
Psoriasis and infection. A clinical practice narrative.
Rademaker M, Agnew K, Anagnostou N, Andrews M, Armour K, Baker C, Foley P, Gebauer K, Gupta M, Marshman G, Rubel D, Sullivan J, Wong LC. Rademaker M, et al. Among authors: rubel d. Australas J Dermatol. 2019 May;60(2):91-98. doi: 10.1111/ajd.12895. Epub 2018 Aug 5. Australas J Dermatol. 2019. PMID: 30079566 Review.
Atopic dermatitis in adults: An Australian management consensus.
Smith S, Baker C, Gebauer K, Rubel D, Frankum B, Soyer HP, Weightman W, Sladden M, Rawlin M, Headley AP, Somerville C, Beuth J, Logan N, Mewton E, Foley P. Smith S, et al. Among authors: rubel d. Australas J Dermatol. 2020 Feb;61(1):23-32. doi: 10.1111/ajd.13124. Epub 2019 Aug 1. Australas J Dermatol. 2020. PMID: 31372984
64 results